Raymond James Financial Services Advisors’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $4.27M | Buy |
|
|||||
|
2024
Q2 | $3.38M | Buy |
|
|||||
|
2024
Q1 | $2.46M | Buy |
|
|||||
|
2023
Q4 | $1.77M | Buy |
|
|||||
|
2023
Q3 | $1.58M | Buy |
|
|||||
|
2023
Q2 | $984K | Sell |
|
|||||
|
2023
Q1 | $946K | Sell |
|
|||||
|
2022
Q4 | $921K | Sell |
|
|||||
|
2022
Q3 | $1.06M | Sell |
|
|||||
|
2022
Q2 | $1.28M | Buy |
|
|||||
|
2022
Q1 | $1.17M | Buy |
|
|||||
|
2021
Q4 | $404K | Buy |
|
|||||
|
2021
Q3 | $473K | Buy |
|